Medtronic Operating Income Growth & History (MDT)
Medtronic's operating income was $6.47B for fiscal 2026.
View full Medtronic company overviewMedtronic annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-04-24 | $6.47B | $512.0M | +8.60% |
| 2025 | 2025-04-25 | $5.96B | $811.0M | +15.77% |
| 2024 | 2024-04-26 | $5.14B | −$341.0M | −6.22% |
| 2023 | 2023-04-28 | $5.49B | −$267.0M | −4.64% |
| 2022 | 2022-04-29 | $5.75B | $1.27B | +28.28% |
| 2021 | 2021-04-30 | $4.48B | −$307.0M | −6.41% |
| 2020 | 2020-04-24 | $4.79B | −$1.48B | −23.56% |
| 2019 | 2019-04-26 | $6.27B | −$372.0M | −5.60% |
| 2018 | 2018-04-27 | $6.64B | $1.26B | +23.35% |
| 2017 | 2017-04-28 | $5.38B | $22.0M | +0.41% |
| 2016 | 2016-04-29 | $5.36B | $1.59B | +42.35% |
| 2015 | 2015-04-24 | $3.77B | −$47.0M | −1.23% |
| 2014 | 2014-04-25 | $3.81B | −$589.0M | −13.38% |
| 2013 | 2013-04-26 | $4.40B | — | — |
Medtronic quarterly operating income
| Fiscal quarter | Period ended | Operating income | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-07-31 | $1.76B | $319.0M | +22.08% |
| Q4 2026 | 2026-04-24 | $1.87B | $436.0M | +30.36% |
| Q3 2026 | 2026-01-31 | $1.60B | −$44.0M | −2.67% |
| Q3 2026 | 2026-01-23 | $1.46B | −$182.0M | −11.06% |
| Q2 2026 | 2025-10-24 | $1.69B | $91.0M | +5.71% |
| Q1 2026 | 2025-07-25 | $1.45B | $167.0M | +13.07% |
| Q4 2025 | 2025-04-25 | $1.44B | $383.0M | +36.37% |
| Q3 2025 | 2025-01-24 | $1.65B | $163.0M | +10.99% |
| Q2 2025 | 2024-10-25 | $1.59B | $255.0M | +19.03% |
| Q1 2025 | 2024-07-26 | $1.28B | $10.0M | +0.79% |
| Q4 2024 | 2024-04-26 | $1.05B | −$511.0M | −32.67% |
| Q3 2024 | 2024-01-26 | $1.48B | $91.0M | +6.54% |
| Q2 2024 | 2023-10-27 | $1.34B | −$64.0M | −4.56% |
| Q1 2024 | 2023-07-28 | $1.27B | $143.0M | +12.71% |
| Q4 2023 | 2023-04-28 | $1.56B | −$107.0M | −6.40% |
| Q3 2023 | 2023-01-27 | $1.39B | −$267.0M | −16.09% |
| Q2 2023 | 2022-10-28 | $1.40B | −$159.0M | −10.17% |
| Q1 2023 | 2022-07-29 | $1.13B | $266.0M | +30.97% |
| Q4 2022 | 2022-04-29 | $1.67B | $67.0M | +4.18% |
| Q3 2022 | 2022-01-28 | $1.66B | $382.0M | +29.91% |
| Q2 2022 | 2021-10-29 | $1.56B | $633.0M | +68.06% |
| Q1 2022 | 2021-07-30 | $859.0M | $186.0M | +27.64% |
| Q4 2021 | 2021-04-30 | $1.60B | $1.29B | +407.59% |
| Q3 2021 | 2021-01-29 | $1.28B | −$362.0M | −22.09% |
| Q2 2021 | 2020-10-30 | $930.0M | −$421.0M | −31.16% |
| Q1 2021 | 2020-07-31 | $673.0M | −$812.0M | −54.68% |
| Q4 2020 | 2020-04-24 | $316.0M | −$1.63B | −83.76% |
| Q3 2020 | 2020-01-24 | $1.64B | $97.0M | +6.29% |
| Q2 2020 | 2019-10-25 | $1.35B | −$193.0M | −12.50% |
| Q1 2020 | 2019-07-26 | $1.49B | $249.0M | +20.15% |
| Q4 2019 | 2019-04-26 | $1.95B | $18.0M | +0.93% |
| Q3 2019 | 2019-01-25 | $1.54B | $106.0M | +7.38% |
| Q2 2019 | 2018-10-26 | $1.54B | −$350.0M | −18.48% |
| Q1 2019 | 2018-07-27 | $1.24B | −$146.0M | −10.56% |
| Q4 2018 | 2018-04-27 | $1.93B | $244.0M | +14.49% |
| Q3 2018 | 2018-01-26 | $1.44B | $289.0M | +25.20% |
| Q2 2018 | 2017-10-27 | $1.89B | $509.0M | +36.75% |
| Q1 2018 | 2017-07-28 | $1.38B | $215.0M | +18.42% |
| Q4 2017 | 2017-04-28 | $1.68B | $109.0M | +6.92% |
| Q3 2017 | 2017-01-27 | $1.15B | −$208.0M | −15.35% |
| Q2 2017 | 2016-10-28 | $1.39B | $85.0M | +6.54% |
| Q1 2017 | 2016-07-29 | $1.17B | $36.0M | +3.18% |
| Q4 2016 | 2016-04-29 | $1.57B | $1.20B | +322.25% |
| Q3 2016 | 2016-01-29 | $1.35B | $80.0M | +6.27% |
| Q2 2016 | 2015-10-30 | $1.30B | $270.0M | +26.21% |
| Q1 2016 | 2015-07-31 | $1.13B | $43.0M | +3.95% |
| Q4 2015 | 2015-04-24 | $373.0M | — | — |
| Q3 2015 | 2015-01-23 | $1.27B | — | — |
| Q2 2015 | 2014-10-24 | $1.03B | — | — |
| Q1 2015 | 2014-07-25 | $1.09B | — | — |
Medtronic operating income trends
Over the last five fiscal years, Medtronic's operating income increased from $4.48B to $6.47B, a change of $1.98B. The latest reported quarter, Q1 2027, shows $1.76B.
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
SEC-reported operating income
TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medtronic source filings ↗Community posts
Medtronic begins European clinical use of its Stealth AXiS surgical system
Medtronic ($MDT) announced the first European procedures using its Stealth AXiS surgical system, with more than 23 procedures performed across seven sites in Germany, the UK, Italy and Spain. The initial experience includes spinal surgery. ...